We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
Cap. Flow
+$293M
Cap. Flow %
57.02%
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$4.08M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.92M
3
SMAR
Smartsheet Inc.
SMAR
+$2.98M
4
LEN icon
Lennar Class A
LEN
+$2.74M
5
DOW icon
Dow Inc
DOW
+$2.55M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.12M
2
HOLX
Hologic
HOLX
+$2.01M
3
MPC icon
Marathon Petroleum
MPC
+$1.66M
4
KO icon
Coca-Cola
KO
+$1.58M
5
JBL icon
Jabil
JBL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Industrials 18.09%
3 Consumer Discretionary 13.93%
4 Healthcare 10.29%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNIT
751
Uniti Group
UNIT
$2.32B
$175K 0.03%
+29,725
New +$170K
TAST
752
DELISTED
Carrols Restaurant Group, Inc.
TAST
$174K 0.03%
+18,260
New +$169K
GTN icon
753
Gray Television
GTN
$552M
$173K 0.03%
+27,444
New +$210K
ONTF
754
DELISTED
ON24
ONTF
$173K 0.03%
24,282
+10,855
+81% +$78.8K
AMPY icon
755
Amplify Energy
AMPY
$166M
$173K 0.03%
+26,195
New +$159K
MIR icon
756
Mirion Technologies
MIR
$3.91B
$172K 0.03%
+15,134
New +$152K
AVO icon
757
Mission Produce
AVO
$1.17B
$171K 0.03%
+14,444
New +$154K
CALY
758
Callaway Golf Company
CALY
$3.14B
$171K 0.03%
10,585
-700
-6% -$9.95K
OCFC icon
759
OceanFirst Financial
OCFC
$1.91B
$171K 0.03%
+10,415
New +$168K
SBH icon
760
Sally Beauty Holdings
SBH
$1.58B
$169K 0.03%
+13,647
New +$171K
EHTH icon
761
eHealth
EHTH
$43.9M
$168K 0.03%
+27,898
New +$185K
UDMY
762
DELISTED
Udemy
UDMY
$168K 0.03%
+15,288
New +$190K
OSUR icon
763
OraSure Technologies
OSUR
$279M
$165K 0.03%
+26,814
New +$195K
HLX icon
764
Helix Energy Solutions
HLX
$1.41B
$162K 0.03%
+14,984
New +$146K
VNDA icon
765
Vanda Pharmaceuticals
VNDA
$302M
$161K 0.03%
+39,229
New +$157K
ARRY icon
766
Array Technologies
ARRY
$855M
$160K 0.03%
+10,728
New +$148K
CIO
767
DELISTED
City Office REIT
CIO
$159K 0.03%
+30,526
New +$154K
CLAR icon
768
Clarus
CLAR
$143M
$159K 0.03%
23,511
+10,548
+81% +$65K
ALIT icon
769
Alight
ALIT
$407M
$158K 0.03%
+802
New +$145K
FNA
770
DELISTED
Paragon 28, Inc.
FNA
$154K 0.03%
+12,439
New +$148K
RRGB icon
771
Red Robin
RRGB
$152M
$149K 0.03%
+19,420
New +$179K
MACK
772
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$148K 0.03%
+10,006
New +$141K
TFSL icon
773
TFS Financial
TFSL
$4.93B
$146K 0.03%
+11,595
New +$153K
ADPT icon
774
Adaptive Biotechnologies
ADPT
$3.97B
$141K 0.03%
+43,859
New +$170K
DXLG icon
775
Destination XL Group
DXLG
$35.4M
$137K 0.03%
+37,951
New +$149K
29 30
31
32 33

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.

  • Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
  • Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
  • Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
  • Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
  • Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
  • Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.